+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Diarrheal"

From
From
From
MYTESI Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

MYTESI Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
From
Gastrointestinal OTC Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Gastrointestinal OTC Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 160 Pages
  • Global
From
Market Spotlight: Irritable Bowel Syndrome (IBS) (2020) - Product Thumbnail Image

Market Spotlight: Irritable Bowel Syndrome (IBS) (2020)

  • Report
  • March 2020
  • 49 Pages
  • Global
From
Loading Indicator

The Anti Diarrheal market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Anti Diarrheal drugs are used to treat diarrhea, which is a common symptom of many gastrointestinal disorders. These drugs work by reducing the amount of water and electrolytes lost in the stool, and by slowing down the movement of the intestines. Commonly used Anti Diarrheal drugs include loperamide, diphenoxylate, and bismuth subsalicylate. The Anti Diarrheal market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Johnson & Johnson, and Novartis. Other companies in the market include Sanofi, Bayer, AstraZeneca, and Daiichi Sankyo. Show Less Read more